The FDA approved external trigeminal nerve stimulation (TNS) in 2019 as the first non-drug device for treating ADHD, ...
Zycubo received breakthrough therapy, fast track, rare paediatric disease and orphan drug designations from the FDA.
The Senate Committee on Health, Education, Labor and Pensions (HELP) is holding a hearing Wednesday morning focused on ...
Sen. Lindsey Graham (R-S.C.) will give remarks Wednesday afternoon about his opposition to abortion pills, which have been ...
FDA approves first brain stimulation device for home depression treatment. Flow Neuroscience's FL-100 headset uses electrical ...
Pharmaceutical company Boehringer Ingelheim said on Monday the U.S. Food and Drug Administration had approved its chewable ...
The U.S. Food and Drug Administration (FDA) has granted full approval of Laverdia, a drug to treat dogs with lymphoma, a type ...
4don MSN
Legal questions swirl around FDA's new expedited drug program, including who should sign off
A plan to slash Food and Drug Administration drug review times is raising alarms at the public health agency that's been ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
More than half a dozen major drugmakers are participating in the Trump administration's speedier review program for new medicines, yet other leading pharmaceutical companies are hesitating over what ...
After Reviewing Historical Use and Modern Safety Evidence, Officially Confirms Kava is a Food Under Federal Law LOS ANGELES, CA / ACCESS Newswire / December 22, 2025 / The United States Food and Drug ...
The FDA has granted full approval to verdinexor tablets (Laverdia; Anivive Lifesciences) for the treatment of dogs with lymphoma. The approval gives veterinarians a promising new oral avenue for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback